Cart (0 Items)
Your cart is currently empty.
View ProductsCaplacizumab Biosimilar – Anti-VWF A1 domain mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | VH-VH |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Caplacizumab Biosimilar - Anti-VWF A1 domain mAb - Research Grade |
|---|---|
| Source | CAS 915810-67-2 |
| Species | Humanized |
| Molecular weight | 28kDa |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Caplacizumab,ALX-0081,PMP12A2h1-linker AAA-PMP12A2h1,caplacizumab-yhdp,VWF A1 domain,anti-VWF A1 domain |
| Reference | PX-TA1278 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | VH-VH |
| Clonality | Monoclonal Antibody |
Description of Caplacizumab Biosimilar - Anti-VWF A1 domain mAb - Research Grade
General information on Anti-VWF A1 domain[Homo sapiens] (Caplacizumab) Monoclonal Antibody
Caplacizumab is a humanized single-variable-domain immunoglobulin. Caplacizumab is used in the treatment of Thrombotic Thrombocytopenic Purpura (aTTP). It is marketed under the trade name Cablivi.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.